| | | Index Performance | | Index | Sensex | Nifty | | Open | 12,570.52 | 3,639.35 | | High | 12,638.78 | 3,683.60 | | Low | 12,316.10 | 3,573.85 | | Today's Cls | 12,430.40 | 3,608.55 | | Prev Cls | 12,543.85 | 3,643.60 | | Change | -113.45 | -35.05 | | % Change | -0.90 | -0.96 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Tata Motors | 749.45 | 3.25 | | IOB | 97.50 | 3.12 | | Gujarat Gas | 1,350.00 | 3.02 | | Orchid Chemicals | 248.90 | 2.28 | | BPCL | 300.05 | 2.16 | | Losers | | Godrej Consumer | 139.15 | -5.50 | | Suzlon Energy | 964.35 | -5.43 | | Syngenta | 445.00 | -5.39 | | Century Textiles | 507.25 | -4.61 | | Dabur India | 84.70 | -4.56 | | | Market Statistics | | - | BSE | NSE | | Advances | 817 | 334 | | Declines | 1,738 | 983 | | Unchanged | 64 | 41 | | Volume(Nos) | 17.47cr | 27.50cr | | | | | | Market Commentary | | | Market slips, sheds 113 points | | Heavy selling in capital goods, consumer durables and banking stocks triggered a major sell-off in the market and the Sensex shed nearly 1% during the day. | | The market opened in positive territory despite negative Asian indices led by the buying in metal and pharma stocks. However the Sensex came off | | | its high on substantial selling in heavyweight, telecom and capital goods stocks and slipped into the red. After wiping out the early gains of 68 points, the market remained weak throughout the session. The Sensex slipped further in the afternoon on reports of a rise in the inflation rate and touched a low of 12316, down 323 points from the day's high. There was buying at lower levels and the Sensex managed to pare some losses towards the close and end the session at 12430, down 113 points. The Nifty shed 35 points and closed at 3609.
The breadth of the market was negative. Of the 2,619 scrips traded on the BSE, 1,738 stocks declined, 817 stocks advanced and 64 stocks ended unchanged. Except the BSE Oil & Gas Index all the sectoral indices of the BSE ended in negative territory. The BSE CG Index shed 2.60% at 8335. The BSE Bankex, the BSE Teck Index, the BSE CD Index and the BSE PSU Index were down around 1% each.
Reliance Communications triggered a major sell-off in the market and tumbled 3.52% at Rs377. Among the other major losers L&T dropped 3.03% at Rs1,449, Hero Honda declined 3% at Rs648, BHEL lost 2.57% at Rs1,956, Maruti shed 2.25% at Rs779, Gujarat Ambuja slumped 2.22% at Rs104, Cipla slipped 1.65% at Rs224 and ONGC dipped 1.61% at Rs762. ITC, Infosys, HDFC Bank, Reliance Energy, Bharti Airtel, ICICI Bank, and ACC lost around 1% each. However, Tata Motors managed to report gains of 3.25% at Rs749, Ranbaxy added 1.61% at Rs316, Reliance Industries gained 1.25% at Rs1,230, Dr Reddy's advanced 1.07% at Rs682 and Wipro closed with marginal gains at Rs566. | | | Movers & Shakers | - Gail India slipped despite signing a memorandum of understanding with Reliance Industries for cooperation in the gas sector.
- Ranbaxy Laboratories notched up gains on receiving a tentative approval from the US FDA to manufacture and market Zolpidem Tartrate tablets.
- Satyam Computer Services declined despite announcing a services and technology collaboration with 7Hills Business Solutions for offering supply chain solutions.
- Punj Lloyd slipped despite announcing that it will construct UK's first world scale bio-ethanol plant.
| | | |
Select capital goods stocks took a heavy beating on the bourses. Triveni Engineering tanked 5.84% at Rs50, Areva fell 4.70% at Rs994 and Kirloskar Brothers lost 4.61% at Rs372.
Over 63.65 lakh Idea Cellular shares changed hands on the BSE followed by Reliance Communications (36.54 lakh shares), SAIL (18.48 lakh shares), ITC (17.64 lakh shares) and Parsvanath Developers (15.22 lakh shares).
Reliance Industries was the most actively traded counter on the BSE with a turnover of Rs152 crore followed by Reliance Communications (Rs138 crore), SBI (Rs78 crore), Idea Cellular (Rs58 crore) and Infosys (Rs57 crore).
| | | | | | | | European Indices at 17:04 IST on 16-03-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 6114.00 | -19.20 | -0.31 | | CAC 40 Index | 5357.92 | -31.93 | -0.59 | | DAX Index | 6545.78 | -39.69 | -0.60 | | | | | | | | | | | Asian Indices at close on 16-03-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 16744.15 | -116.24 | -0.69 | | Hang Seng Index | 18953.50 | -15.94 | -0.08 | | Kospi Index | 1427.88 | 0.95 | 0.07 | | Straits Times Index | 3068.75 | -25.85 | -0.84 | | Jakarta Composite Index | 1777.89 | 1.53 | 0.09 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
No comments:
Post a Comment